Cipher Pharmaceuticals Inc. (CPH.TO)
| Previous Close | 8.50 |
| Open | 8.52 |
| Bid | 8.50 x 0 |
| Ask | 8.55 x 0 |
| Day's Range | 8.51 - 8.57 |
| 52 Week Range | 3.11 - 9.98 |
| Volume | |
| Avg. Volume | 46,537 |
| Market Cap | 205.153M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | 7.81 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024Time:8:30 AM-5:00 PM ETLocation: Metro Toronto Convention Centre, North Building 255 Front St W Toronto, Ontario M5V 2W6 CEO Craig Mull ...
- CNW Group
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the year ended December 31, 2023.
- CNW Group
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and full year of 2023 after the market close on Thursday, March 14, 2024. The Company will also hold a conference call on Friday, March 15 at 8:30 ET to discuss the results and corporate developments.
